Charles B Haaser - Net Worth and Insider Trading

Charles B Haaser Net Worth

The estimated net worth of Charles B Haaser is at least $909,090 dollars as of 2024-05-05. Charles B Haaser is the Principal Accounting Officer of Abiomed Inc and owns about 2,379 shares of Abiomed Inc (ABMD) stock worth over $906,447. Charles B Haaser is also the VP Fin and CAO of Yield10 Bioscience Inc and owns about 472 shares of Yield10 Bioscience Inc (YTEN) stock worth over $2,643. Details can be seen in Charles B Haaser's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles B Haaser has not made any transactions after 2021-12-03 and currently still holds the listed stock(s).

Transaction Summary of Charles B Haaser

To

Charles B Haaser Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles B Haaser owns 2 companies in total, including Yield10 Bioscience Inc (YTEN) , and Abiomed Inc (ABMD) .

Click here to see the complete history of Charles B Haaser’s form 4 insider trades.

Insider Ownership Summary of Charles B Haaser

Ticker Comapny Transaction Date Type of Owner
YTEN Yield10 Bioscience Inc 2022-03-01 VP Fin and CAO
ABMD Abiomed Inc 2006-05-31 Principal Financial Officer & other: Acting Chief Financial Officer

Charles B Haaser Latest Holdings Summary

Charles B Haaser currently owns a total of 2 stocks. Among these stocks, Charles B Haaser owns 2,379 shares of Abiomed Inc (ABMD) as of May 31, 2006, with a value of $906,447 and a weighting of 99.71%. Charles B Haaser also owns 472 shares of Yield10 Bioscience Inc (YTEN) as of December 3, 2021, with a value of $2,643 and a weighting of 0.29%.

Latest Holdings of Charles B Haaser

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABMD Abiomed Inc 2006-05-31 2,379 381.02 906,447
YTEN Yield10 Bioscience Inc 2021-12-03 472 5.60 2,643

Holding Weightings of Charles B Haaser


Charles B Haaser Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles B Haaser has made a total of 0 transactions in Abiomed Inc (ABMD) over the past 5 years. The most-recent trade in Abiomed Inc is the sale of 1,500 shares on May 31, 2006, which brought Charles B Haaser around $20,040.

According to the SEC Form 4 filings, Charles B Haaser has made a total of 1 transactions in Yield10 Bioscience Inc (YTEN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Yield10 Bioscience Inc is the acquisition of 100 shares on December 3, 2021, which cost Charles B Haaser around $10,080.

Insider Trading History of Charles B Haaser

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles B Haaser Trading Performance

GuruFocus tracks the stock performance after each of Charles B Haaser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles B Haaser is 14.41%. GuruFocus also compares Charles B Haaser's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles B Haaser within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Charles B Haaser's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Charles B Haaser

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 26.11
Relative Return to S&P 500(%) 20.42

Charles B Haaser Ownership Network

Ownership Network List of Charles B Haaser

No Data

Ownership Network Relation of Charles B Haaser


Charles B Haaser Owned Company Details

What does Yield10 Bioscience Inc do?

Who are the key executives at Yield10 Bioscience Inc?

Charles B Haaser is the VP Fin and CAO of Yield10 Bioscience Inc. Other key executives at Yield10 Bioscience Inc include 10 percent owner Jack W Schuler , VP Planning and Comms Lynne H Brum , and VP Research & CSO Kristi Snell .

Yield10 Bioscience Inc (YTEN) Insider Trades Summary

Over the past 18 months, Charles B Haaser made no insider transaction in Yield10 Bioscience Inc (YTEN). Other recent insider transactions involving Yield10 Bioscience Inc (YTEN) include a net purchase of 705,940 shares made by Jack W Schuler ,

In summary, during the past 3 months, insiders sold 0 shares of Yield10 Bioscience Inc (YTEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,443 shares of Yield10 Bioscience Inc (YTEN) were sold and 45,857 shares were bought by its insiders, resulting in a net purchase of 29,414 shares.

Yield10 Bioscience Inc (YTEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Yield10 Bioscience Inc Insider Transactions

No Available Data

Charles B Haaser Mailing Address

Above is the net worth, insider trading, and ownership report for Charles B Haaser. Currently GuruFocus does not have mailing address information for Charles B Haaser.

Discussions on Charles B Haaser

No discussions yet.